Breast milk drug study pulled before it began
NCT ID NCT06181630
First seen Jan 02, 2026 · Last updated May 23, 2026 · Updated 14 times
Summary
This study was designed to measure how much of the drug ozanimod passes into breast milk and how it might affect breastfed babies. It planned to include lactating women already taking ozanimod for medical reasons. However, the study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATING WOMEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PPD Las Vegas Clinical Research Unit
Las Vegas, Nevada, 89113-2228, United States
Conditions
Explore the condition pages connected to this study.